- Organizations: Visiox Pharma
Business
Ocuvex Therapeutics to merge with Visiox Pharmaceuticals
Deal includes Visiox’s OMLONTI, indicated to treat glaucoma and ocular hypertension.Products
Visiox Pharma acquires US rights to Omlonti
Santen agrees to sale of prescription-based eye drop indicated for the treatment of glaucoma and ocular hypertension.Archives